Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barnache

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Blood|October 6, 2001
Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblastsS Barnache, P Mayeux, B Payrastre, et al.
Oncogene|October 26, 2005
Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive geneS Barnache, E Le Scolan, O Kosmider, et al.
The Journal of Biological Chemistry|March 28, 1998
The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLSM Hallier, A Lerga, S Barnache, et al.
Oncogene|July 14, 1998
Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutationS Barnache, F Wendling, C Lacombe, et al.
Oncogene|September 26, 2001
Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblastsE L Scolan, F Wendling, S Barnache, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Blood|October 6, 2001
Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblastsS Barnache, P Mayeux, B Payrastre, et al.
Oncogene|October 26, 2005
Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive geneS Barnache, E Le Scolan, O Kosmider, et al.
The Journal of Biological Chemistry|March 28, 1998
The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLSM Hallier, A Lerga, S Barnache, et al.
Oncogene|July 14, 1998
Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutationS Barnache, F Wendling, C Lacombe, et al.
Oncogene|September 26, 2001
Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblastsE L Scolan, F Wendling, S Barnache, et al.
Pageof 1